0000899243-17-023789.txt : 20171006 0000899243-17-023789.hdr.sgml : 20171006 20171006184907 ACCESSION NUMBER: 0000899243-17-023789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171004 FILED AS OF DATE: 20171006 DATE AS OF CHANGE: 20171006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS CENTRAL INDEX KEY: 0001413822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 171128333 MAIL ADDRESS: STREET 1: 333 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia Inc CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-04 0 0001552451 MyoKardia Inc MYOK 0001413822 GIANAKAKOS ANASTASIOS C/O MYOKARDIA, INC. 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Common Stock 2017-10-04 4 M 0 4300 1.5068 A 512463 D Common Stock 2017-10-04 4 S 0 4300 40.8603 D 508163 D Common Stock 181169 I By Reporting Person's Trust Stock Option (Right to Buy) 1.5068 2017-10-04 4 M 0 4300 0.00 D 2025-06-03 Common Stock 4300 162212 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Represents the weighted average sale price of the shares sold ranging from $40.50 to $41.45 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. 25% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019. /s/ Jake Bauer, Attorney-in-Fact 2017-10-06